PSI Advisors’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13
Closed -$665 857
2023
Q1
$665 Hold
13
﹤0.01% 701
2022
Q4
$845 Hold
13
﹤0.01% 677
2022
Q3
$2K Hold
13
﹤0.01% 615
2022
Q2
$1K Buy
+13
New +$1.59K ﹤0.01% 710

Other funds holding DNA

PSI Advisors's DNA Position: Q2 2023 in Review

PSI Advisors sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 13 shares — an estimated $665 sold.

PSI Advisors first reported a position in DNA in Q2 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

  • PSI Advisors reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
  • PSI Advisors sold 13 Ginkgo Bioworks shares in Q2 2023, an estimated $665.
  • PSI Advisors first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 4 quarters.
  • PSI Advisors's Ginkgo Bioworks position peaked at $2K in Q3 2022.
  • 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on PSI Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.